Matches in Wikidata for { <http://www.wikidata.org/entity/Q91747369> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q91747369 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91747369 description "scientific article published on 08 April 2020" @default.
- Q91747369 description "wetenschappelijk artikel" @default.
- Q91747369 description "наукова стаття, опублікована 8 квітня 2020" @default.
- Q91747369 name "The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways" @default.
- Q91747369 name "The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways" @default.
- Q91747369 type Item @default.
- Q91747369 label "The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways" @default.
- Q91747369 label "The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways" @default.
- Q91747369 prefLabel "The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways" @default.
- Q91747369 prefLabel "The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways" @default.
- Q91747369 P1433 Q91747369-AC8BDC38-036B-4AB6-B342-D90A4FF98382 @default.
- Q91747369 P1476 Q91747369-6E11E9B7-AE10-4FF3-A738-63758368F60F @default.
- Q91747369 P2093 Q91747369-0B4E0374-016C-44F6-8B39-05DAC0590549 @default.
- Q91747369 P2093 Q91747369-198E8F08-1A7E-4AAD-B926-9DD810BF0040 @default.
- Q91747369 P2093 Q91747369-421C2872-58EF-4A93-A97A-F10EA863DC35 @default.
- Q91747369 P2093 Q91747369-B6C3B979-0D2F-459B-BAEC-5E6F2872AABA @default.
- Q91747369 P2860 Q91747369-C869C9EF-354A-4891-819C-9FC6DF5017A2 @default.
- Q91747369 P31 Q91747369-F7200F54-BFAB-4C49-980B-9E64E33AAE3A @default.
- Q91747369 P356 Q91747369-5316032B-85A2-44F3-9873-AAB585634F52 @default.
- Q91747369 P577 Q91747369-DD9E4598-2D29-4575-A411-14C5FF45F698 @default.
- Q91747369 P698 Q91747369-641F8008-E728-4274-9A89-39E18B5DCDF5 @default.
- Q91747369 P921 Q91747369-287DD784-1994-43A0-B747-E22C90C2058E @default.
- Q91747369 P921 Q91747369-90C536BA-4AF3-41C3-98AD-BF005D94DFF3 @default.
- Q91747369 P356 S00210-020-01863-9 @default.
- Q91747369 P698 32270258 @default.
- Q91747369 P1433 Q1468251 @default.
- Q91747369 P1476 "The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways" @default.
- Q91747369 P2093 "Ahmed M Mansour" @default.
- Q91747369 P2093 "Amira M Abo-Youssef" @default.
- Q91747369 P2093 "Mohamed Abd-Elbaset" @default.
- Q91747369 P2093 "Osama M Ahmed" @default.
- Q91747369 P2860 Q52671363 @default.
- Q91747369 P31 Q13442814 @default.
- Q91747369 P356 "10.1007/S00210-020-01863-9" @default.
- Q91747369 P577 "2020-04-08T00:00:00Z" @default.
- Q91747369 P698 "32270258" @default.
- Q91747369 P921 Q1148337 @default.
- Q91747369 P921 Q974135 @default.